GlassScriptPhysician profile
Megan Bobeck
NPI 1285011585
$657.39
in general payments reported to CMS, 2019-2025
18 companies · $28.27 in 2025
The $28.27 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.05 · 2022: $336 · 2023: $159 · 2024: $76.72 · 2025: $28.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $149.67 | 2022 | |
| Pfizer INC. | $81.62 | 2022-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $60.37 | 2021-2023 | Imbruvica |
| E.R. Squibb & Sons, L.L.C. | $50.37 | 2024 | Opdivo |
| Celgene Corporation | $47.97 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $46.13 | 2022-2023 | |
| Glaxosmithkline, LLC. | $26.35 | 2024 | Zejula, Jemperli |
| Alexion Pharmaceuticals, INC. | $24.52 | 2023 | Ultomiris |
| Sobi, INC | $22.43 | 2022 | |
| Incyte Corporation | $21.95 | 2022 | |
| Genentech USA, INC. | $21.46 | 2023 | Alecensa, Tecentriq, Gavreto |
| Lilly USA, LLC | $19.85 | 2023 | Verzenio, Jaypirca |
| Merck Sharp & Dohme LLC | $17.85 | 2022 | |
| Janssen Biotech, INC. | $14.05 | 2022 | |
| Beigene USA, INC. | $13.67 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmaessentia USA Corporation | $13.28 | 2023 | Besremi |
| Janssen Pharmaceuticals, INC | $13.23 | 2022 | |
| Array Biopharma INC | $12.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Bobeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.